(NOC) Northrop Grumman - Ratings and Ratios
Aircraft, Missiles, Satellites, Sensors, Radar, Drones
NOC EPS (Earnings per Share)
NOC Revenue
Description: NOC Northrop Grumman
Northrop Grumman (NYSE:NOC) is a global aerospace and defense technology firm headquartered in Falls Church, Virginia, with operations across the United States, Asia-Pacific, Europe, and other international markets.
Its Aeronautics Systems segment builds and modernizes a broad portfolio of aircraft, ranging from tactical fighters and air-dominance platforms to unmanned autonomous systems such as high-altitude long-endurance (HALE) surveillance drones. The segment also delivers airborne battle-management, command-and-control (C2) suites, and strategic long-range strike capabilities.
The Defense Systems segment focuses on strategic deterrent and missile-defense solutions, including precision-strike weapons, hypersonic propulsion, solid-rocket motors, and advanced gun systems. It also provides life-cycle services-sustainment, modernization, and training-for both manned and unmanned platforms, generating a sizable recurring-revenue stream.
Mission Systems supplies integrated C4ISR (command, control, communications, computers, intelligence, surveillance, and reconnaissance) capabilities, encompassing radar, EO/IR, acoustic sensors, electronic warfare, cyber solutions, and microelectronics. These offerings are increasingly tied to the U.S. Department of Defense’s push toward multi-domain operations.
Space Systems designs and manufactures satellites, spacecraft subsystems, launch vehicles, and missile-defense interceptors, positioning the company within the fast-growing commercial and government space markets.
Key quantitative signals (as of FY 2024) include: ≈ $19 billion in annual revenue, a backlog of roughly $70 billion-about 3.5 × annual sales-indicating strong order flow; and R&D spending of ~ $2.5 billion (≈ 13 % of revenue), underscoring a commitment to next-generation hypersonic and autonomous technologies. The sector is driven by sustained U.S. defense budget growth (projected FY 2025 FY-2028 increase of ~ 5 % YoY) and heightened geopolitical competition in hypersonic weapons, which should buoy demand for Northrop’s high-tech missile and space assets.
For readers looking to deepen their analysis, a quick look at ValueRay’s analyst notes can surface additional forward-looking valuation metrics and scenario modeling that may help quantify the upside from these macro-driven tailwinds.
NOC Stock Overview
| Market Cap in USD | 85,125m |
| Sub-Industry | Aerospace & Defense |
| IPO / Inception | 1981-12-31 |
NOC Stock Ratings
| Growth Rating | 60.8% |
| Fundamental | 72.0% |
| Dividend Rating | 62.0% |
| Return 12m vs S&P 500 | 2.66% |
| Analyst Rating | 3.96 of 5 |
NOC Dividends
| Dividend Yield 12m | 1.41% |
| Yield on Cost 5y | 3.02% |
| Annual Growth 5y | 9.16% |
| Payout Consistency | 96.9% |
| Payout Ratio | 32.2% |
NOC Growth Ratios
| Growth Correlation 3m | 65.8% |
| Growth Correlation 12m | 57.5% |
| Growth Correlation 5y | 82.8% |
| CAGR 5y | 11.14% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.50 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.00 |
| Sharpe Ratio 12m | 1.34 |
| Alpha | 12.54 |
| Beta | 0.131 |
| Volatility | 19.61% |
| Current Volume | 452.8k |
| Average Volume 20d | 784.2k |
| Stop Loss | 600.3 (-3%) |
| Signal | 0.17 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (3.94b TTM) > 0 and > 6% of Revenue (6% = 2.43b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -2.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 0.97% (prev 3.33%; Δ -2.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 2.97b <= Net Income 3.94b (YES >=105%, WARN >=100%) |
| Net Debt (15.62b) to EBITDA (6.83b) ratio: 2.29 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (144.0m) change vs 12m ago -2.51% (target <= -2.0% for YES) |
| Gross Margin 19.33% (prev 16.80%; Δ 2.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 83.40% (prev 85.51%; Δ -2.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.30 (EBITDA TTM 6.83b / Interest Expense TTM 650.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.30
| (A) 0.01 = (Total Current Assets 13.85b - Total Current Liabilities 13.46b) / Total Assets 49.45b |
| (B) 0.31 = Retained Earnings (Balance) 15.45b / Total Assets 49.45b |
| (C) 0.11 = EBIT TTM 5.39b / Avg Total Assets 48.56b |
| (D) 0.46 = Book Value of Equity 15.47b / Total Liabilities 33.98b |
| Total Rating: 2.30 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.98
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 1.30% = 0.65 |
| 3. FCF Margin 3.23% = 0.81 |
| 4. Debt/Equity 1.13 = 1.89 |
| 5. Debt/Ebitda 2.29 = -0.56 |
| 6. ROIC - WACC (= 9.36)% = 11.70 |
| 7. RoE 26.09% = 2.17 |
| 8. Rev. Trend 54.61% = 4.10 |
| 9. EPS Trend 4.42% = 0.22 |
What is the price of NOC shares?
Over the past week, the price has changed by +0.06%, over one month by +7.72%, over three months by +19.23% and over the past year by +17.91%.
Is Northrop Grumman a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NOC is around 632.65 USD . This means that NOC is currently overvalued and has a potential downside of 2.22%.
Is NOC a buy, sell or hold?
- Strong Buy: 10
- Buy: 4
- Hold: 11
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NOC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 608.1 | -1.7% |
| Analysts Target Price | 608.1 | -1.7% |
| ValueRay Target Price | 686.6 | 10.9% |
Last update: 2025-09-30 03:53
NOC Fundamental Data Overview
P/E Trailing = 21.9299
P/E Forward = 20.3252
P/S = 2.1018
P/B = 5.5022
P/EG = 3.5074
Beta = 0.131
Revenue TTM = 40.50b USD
EBIT TTM = 5.39b USD
EBITDA TTM = 6.83b USD
Long Term Debt = 15.16b USD (from longTermDebt, last quarter)
Short Term Debt = 551.0m USD (from shortTermDebt, last quarter)
Debt = 17.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.62b USD (from netDebt column, last quarter)
Enterprise Value = 100.74b USD (85.13b + Debt 17.52b - CCE 1.90b)
Interest Coverage Ratio = 8.30 (Ebit TTM 5.39b / Interest Expense TTM 650.0m)
FCF Yield = 1.30% (FCF TTM 1.31b / Enterprise Value 100.74b)
FCF Margin = 3.23% (FCF TTM 1.31b / Revenue TTM 40.50b)
Net Margin = 9.74% (Net Income TTM 3.94b / Revenue TTM 40.50b)
Gross Margin = 19.33% ((Revenue TTM 40.50b - Cost of Revenue TTM 32.67b) / Revenue TTM)
Gross Margin QoQ = 21.35% (prev 16.69%)
Tobins Q-Ratio = 2.04 (Enterprise Value 100.74b / Total Assets 49.45b)
Interest Expense / Debt = 0.99% (Interest Expense 173.0m / Debt 17.52b)
Taxrate = 17.73% (253.0m / 1.43b)
NOPAT = 4.44b (EBIT 5.39b * (1 - 17.73%))
Current Ratio = 1.03 (Total Current Assets 13.85b / Total Current Liabilities 13.46b)
Debt / Equity = 1.13 (Debt 17.52b / totalStockholderEquity, last quarter 15.47b)
Debt / EBITDA = 2.29 (Net Debt 15.62b / EBITDA 6.83b)
Debt / FCF = 11.94 (Net Debt 15.62b / FCF TTM 1.31b)
Total Stockholder Equity = 15.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.98% (Net Income 3.94b / Total Assets 49.45b)
RoE = 26.09% (Net Income TTM 3.94b / Total Stockholder Equity 15.12b)
RoCE = 17.81% (EBIT 5.39b / Capital Employed (Equity 15.12b + L.T.Debt 15.16b))
RoIC = 14.89% (NOPAT 4.44b / Invested Capital 29.80b)
WACC = 5.53% (E(85.13b)/V(102.64b) * Re(6.50%) + D(17.52b)/V(102.64b) * Rd(0.99%) * (1-Tc(0.18)))
Discount Rate = 6.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.38%
[DCF Debug] Terminal Value 80.18% ; FCFE base≈1.83b ; Y1≈2.11b ; Y5≈2.95b
Fair Price DCF = 356.2 (DCF Value 51.00b / Shares Outstanding 143.2m; 5y FCF grow 17.44% → 3.0% )
EPS Correlation: 4.42 | EPS CAGR: 12.54% | SUE: 0.92 | # QB: 1
Revenue Correlation: 54.61 | Revenue CAGR: 5.34% | SUE: 0.65 | # QB: 0
Additional Sources for NOC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle